Heat-shock proteins induce T-cell regulation of chronic inflammation

Nature Reviews Immunology

Volumn 5, Issue 4, 2005, Pages 318-330

  Van Eden, Willem ^a   Van Der Zee, Ruurd ^a   Prakken, Berent ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 10; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; IMMUNOLOGIC AGENT; OM 89; PROTEIN DIAPEP277; PROTEIN DNAJP1; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; CHRONIC INFLAMMATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS REACTION; CYTOKINE PRODUCTION; DERMATOMYOSITIS; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFLAMMATORY DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE;

ANIMALS; ARTERIOSCLEROSIS; ARTHRITIS; CHAPERONIN 60; CHRONIC DISEASE; CLINICAL TRIALS; DIABETES MELLITUS, TYPE 1; HSP70 HEAT-SHOCK PROTEINS; HUMANS; INFLAMMATION; T-LYMPHOCYTES;

EID: 17144417382     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1593     Document Type: Review

References (153)

1. Fink, A. L. Chaperone-mediated protein folding. Physiol. Rev. 79, 425-449 (1999).
2. Morimoto, R. I. & Santoro, M. G. Stress-inducible responses and heat shock proteins: new pharmacologic targets for cytoprotection. Nature Biotechnol. 16, 833-838 (1998). This paper reviews the effects of certain drugs (such as aspirin and non-steroidal anti-inflammatory drugs) on HSP expression levels.
3. Nayfor, D. J. & Hartl, F. U. Contribution of molecular chaperones to protein folding in the cytoplasm of prokaryotic and eukaryotic cells. Biochem. Soc. Symp. 68, 45-68 (2001).
4. Kaufmann, S. H. Heat shock proteins and the immune response. Immunol. Today 11, 129-136 (1990).
5. van Noort, J. M. et al. The small heat-shock protein αB-crystallin as candidate autoantigen in multiple sclerosis. Nature 375, 798-801 (1995).
6. van Eden, W. et al. Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature 331, 171-173 (1988). This paper shows that T cells from rats with adjuvant-induced arthritis respond to mycobacterial HSP60. It also shows that immunization with recombinant mycobacterial HSP60 protects against arthritis, providing the first evidence that HSPs are involved in regulation of inflammatory diseases.
7. Zugel, U. & Kaufmann, S. H. Immune response against heat shock proteins in infectious diseases. Immunobiology 201, 22-35 (1999).
8. Lydyard, P. M. & van Eden, W. Heat shock proteins: immunity and immunopathology. Immunol. Today 11, 228-229 (1990).
9. Thole, J. E. et al. Antigenic relatedness of a strongly immunogenic 65 kDa mycobacterial protein antigen with a similarly sized ubiquitous bacterial common antigen. Microb. Pathog. 4, 71-83 (1988).
10. Shinnick, T. M., Vodkln, M. H. & Wiliams, J. C. The Mycobacterium tuberculosis 65-kilodalton antigen is a heat shock protein which corresponds to common antigen and to the Escherichia coli GroEL protein. Infect. Immun. 56, 446-451 (1988).
11. Kaufmann, S. H., Vath, U., Thole, J. E., Van Embden, J. D. & Emmrich, F. Enumeration of T cells reactive with Mycobacterium tuberculosis organisms and specific for the recombinant mycobacterial 64-kDa protein. Eur. J. Immunol. 17, 351-357 (1987). This was the first analysis of the frequency of T cells specific for HSP60 in mice that are immune to infection with M. tuberculosis. The immunodominance of microbial HSP60 was shown by the finding that up to 20% of responding T cells were HSP60 reactive.
12. Janson, A. A. et al. A systematic molecular analysis of the T cell-stimulating antigens from Mycobacterium leprae with T cell clones of leprosy patients. Identification of a novel M. leprae HSP 70 fragment by M. leprae-specific T cells. J. Immunol. 147, 3530-3537 (1991).
13. Shinnick, T. M. Heat shock proteins as antigens of bacterial and parasitic pathogens. Curr. Top. Microbiol. Immunol. 167, 145-160 (1991).
14. Sanchez-Campillo, M. et al. Identification of immunoreactive proteins of Chlamydia trachomatis by Western blot analysis of a two-dimensional electrophoresis map with patient sera, Electrophoresis 20, 2269-2279 (1999).
15. Matthews, R. C. et al. Stress proteins in fungal diseases. Med. Mycol. 36(Suppl. 1), 45-51 (1998).
16. Munk, M. E. et al. T lymphocytes from healthy individuals with specificity to self-epitopes shared by the mycobacterial and human 65-kilodalton heat shock protein. J. Immunol. 143, 2844-2849 (1989).
17. Cohen, I. R. Autoimmunity to chaperonins in the pathogenesis of arthritis and diabetes. Annu. Rev. Immunol. 9, 567-589 (1991).
18. Lopez-Guerrero, J. A. et al. Modulation of adjuvant arthritis in Lewis rats by recombinant vaccinia virus expressing the human 60-kilodalton heat shock protein. Infect. Immun. 61, 4225-4231 (1993).
19. Quintana, F. J., Carmi, P., Mor, F. & Cohen, I. R. Inhibition of adjuvant arthritis by a DNA vaccine encoding human heat shock protein 60. J. Immunol. 169, 3422-3428 (2002).
20. Fischer, H. P., Sharrock, C. E. & Panayi, G. S. High frequency of cord blood lymphocytes against mycobacterial 65-kDa heat-shock protein. Eur. J. Immunol. 22, 1667-1669 (1992).
21. Anderson, M. S. et al. Projection of an immunological self shadow within the thymus by the Aire protein. Science 298, 1395-1401 (2002).
22. Brk, O. S. et al. A role of Hsp60 in autoimmune diabetes: analysis in a transgenic model. Proc. Natl Acad. Sci. USA 93, 1032-1037 (1996). In this study, transgenic overexpression of mouse HSP60 led to diminished susceptibility to diabetes in NOD mice. Furthermore, despite abundant expression of HSP60 in the thymus, T-cell responses to HSP60 still occurred.
23. Mamalaki, C. et al. Tolerance in TCR/cognate antigen double-transgenic mice mediated by incomplete thymic deletion and peripheral receptor downregulation. Dev. Immunol. 4, 299-315 (1996).
24. Minter, L. M. & Osborne, B. A. Cell death in the thymus - it's all a matter of contacts. Semin. immunol. 15, 135-144 (2003).
25. Koga, T. et al. T cells against a bacterial heat shock protein recognize stressed macrophages. Science 245, 1112-1115 (1989).
26. Zugel, U. et al. Crossrecognition by CD8 T cell receptor αβ cytotoxic T tymphocytes of peptides in the self and the mycobacterial hsp60 which share intermediate sequence homology. Eur. J. Immunol. 25, 451-458 (1995).
27. Faure, O. et al. Inducible Hsp70 as target of anticancer immune-therapy; identification of HLA-A*0201 -restricted epitopes. Int. J. Cancer 108, 863-870 (2004).
28. Newcomb, J. R. & Cresswell, P. Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated αβ dimers. J. Immunol. 150, 499-507 (1993).
29. Chicz, R. M. et al. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178, 27-47 (1993).
30. Anderton, S. M., van der Zee, R., Prakken, B., Noordzij, A. & van Eden, W. Activation of T cells recognizing self 60-kD heat shock protein can protect against experimental arthritis. J. Exp. Med. 181, 943-952 (1995). This paper describes the analysis of mycobacterial HSP60 T-cell epitopes in rats with adjuvant-induced arthritis. This led to the concept of self-HSP crossreactivtty, which leads to protection from development of anti-inflammatory disease. Only adoptive transfer of setf-HSP-crossreactive T cells or active immunization with the crossreactivity-inducing conserved peptide could induce protection.
31. Paul, A. G., van Kooten, P. J., van Eden, W. & van der Zee, R. Highly autoproliferative T cells specific for 60-kDa heat shock protein produce IL-4/IL-10 and IFN-γ and are protective in adjuvant arthritis. J. Immunol. 165, 7270-7277 (2000).
32. Durai, M., Gupta, R. S. & Moudgil, K. D. The T cells specific for the carboxyl-terminal determinants of self (rat) heat-shock protein 65 escape tolerance induction and are involved in regulation of autoimmune arthritis. J. Immunol. 172, 2795-2802 (2004).
33. de Graeff-Meeder, E. R. et al. Antibodies to the mycobacterial 65-kD heat shock protein are reactive with synovial tissue of adjuvant arthritic rats and patients with rheumatoid arthritis and osteoarthritis. Am. J. Pathol. 137, 1013-1017 (1990).
34. Boog, C. J. P. et al. Two monoclonal antibodies generated against human hsp60 show reactivity with synovial membranes of patients with juvenile chronic arthritis. J. Exp. Med. 175, 1805-1810 (1992).
35. Res, P. C. et al. Synovial fluid T cell reactivity against 65 kD heat shock protein of mycobacteria in early chronic arthritis. Lancet 332, 478-480 (1988).
36. de Graeff-Meeder, E. R. et al. Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis. Lancet 337, 1368-1372 (1991). This paper was the first to show human HSP60-specific immune responses in patients with chronic arthritis. It also showed that such responses were present in patients with a relatively benign, remitting (oligoarticular) form of the disease. This indicates that the responses to HSP60 were associated with protection against disease.
37. Albani, S. et al. Immune responses to the Escherichia coli dnaJ heat shock protein in juvenile rheumatoid arthritis and their correlation with disease activity. J. Pediatr. 124, 561-565 (1994).
38. Life, P. et al. Responses to Gram negative enteric bacterial antigens by synovial T cells from patients wirth juvenile chronic arthritis: recognition of heal shock protein hsp60. J. Rheumatol. 20, 1388-1396 (1993).
39. Prakken, A. B. J. et al. Autoreactivity to human heat-shock protein 60 predicts disease remission in oligoarticular juvenile rheumatoid arthritis. Arthritis Rheum. 39, 1826-1832 (1996).
40. + T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10. Arthritis Rheum. 48, 2001-2010 (2003). This paper describes the regulatory phenotype of T cells specific for human HSP60 isolated from patients with chronic arthritis.
41. Ramage, J. M. & Gaston, J. S. Depressed proliferative responses by peripheral blood mononuclear cells from early arthritis patients to mycobacterial heat shock protein 60. Rheumatology (Oxford) 38, 631-635 (1999).
42. + T cell subsets according to their expression of CD45 isotypes. J. Immunol. 162, 704-710 (1999).
43. Corrigall, V. M. et al. The human endoplasmic reticulum molecular chaperone BiP is an autoantigen for rheumatoid arthritis and prevents the induction of experimental arthritis. J. Immunol. 166, 1492-1498 (2001).
44. van Boon, J. A. G., van Eden, W., van Roy, J. L. A. M., Lafeber, F. J. P. G. & Bijlsma, J. W. J. Stimulation of suppressive T cell responses by human but not bacterial 60-kD heat-shock protein in synovial fluid of patients with rheumatoid arthritis. J. Clin. Invest. 100, 459-463 (1997).
45. Macht, L. M. et al. Relationship between disease severity and responses by blood mononuclear cells from patients with rheumatoid arthritis to human heat-shock protein 60. Immunology 99, 208-214 (2000).
46. bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J. Immunol. 172, 6435-6443 (2004).
47. Elias, D., Markovits, D., Reshef, T., van der Zee, R. & Cohen, I. R. Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. Proc. Natl Acad. Sci. USA 87, 1576-1580 (1990).
48. Elias, D. & Cohen, I. R. Peptide therapy for diabetes in NOD mice. Lancet 343, 704-706 (1994).
49. Brugman, S. et al. Neonatal oral administration of DiaPep277, combined with hydrolysed casein diet, protects against type 1 diabetes in BB-DP rats. An experimental study. Diabetologia 47, 1331-1333 (2004).
50. Bowman, M. & Atkinson, M. A. Heat shock protein therapy fails to prevent diabetes in NOD mice. Diabetologia 45, 1350-1351 (2002).
51. Quintana, F. J., Carmi, P., Mor, F. & Cohen, I. R. Inhibition of adjuvant-induced arthritis by DNA vaccination with the 70-kD or the 90-kD human heat-shock protein: immune cross-regulation with the 60-kD heat-shock protein. Arthritis Rheum. 50, 3712-3730 (2004).
52. Chandawarkar, R. Y., Wagh, M. S., Kovalchin, J. T. & Srivastava, P. Immune modulation with high-dose heat-shock protein gp96: therapy of murine autoimmune diabetes and encephalomyelitis. Int. Immunol. 16, 615-624 (2004).
53. Ozawa, Y et al. Detection of autoantibodies to the pancreatic islet heat shock protein 60 in insulin-dependent diabetes mellitus. J. Autoimmun. 9, 517-524 (1996).
54. Horvath, L. et al. Antibodies against different epitopes of heat-shock protein 60 in children with type 1 diabetes mellitus. Immunol. Lett. 80, 155-162 (2002).
55. Qin, H. Y. et al. Type 1 diabetes alters anti-hsp90 autoantibody isotype. J. Autoimmun. 20, 237-245 (2003).
56. Weitgasser, R. et al. Antibodies to heat-shock protein 65 and neopterin levels in patients with type 1 diabetes mellitus. Exp. Clin. Endocrinol. Diabetes 111, 127-131 (2003).
57. Figueredo, A. et al. Increased serum levels of IgA antibodies to hsp70 protein in patients with diabetes meilitus: their relationship with vascular complications. Clin. Immunol. Immunopathol. 79, 252-255 (1996).
58. Abulafia-Lapid, R., Gillis, D., Yosef, O., Atlan, H. SCohen, I. R. T cells and autoantibodies to human HSP70 in type 1 diabetes in children. J. Autoimmun. 20, 313-321 (2003).
59. Cohen, I. R. Peptide therapy for type I diabetes: the immunological homunculus and the rationale for vaccination. Diabetologia 45, 1468-1474 (2002),
60. Abulafia-Lapid, R. et al. T cell proliferative responses of type 1 diabetes patients and healthy individuals to human hsp60 and its peptides. J. Autoimmun. 12, 121-129 (1999).
61. Wick, G., Knoflach, M. & Xu, Q. Autoimmune and inflammatory mechanisms in atherosclerosis. Annu. Rev. Immunol. 22, 361-403 (2004).
62. Maron, R. et al. Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice. Circulation 106, 1708-1715 (2002). This is an elegant study that shows the potential of mycobacterial HSP60, when it is administered orally or intranasally, to protect against experimentally induced atherosclerosis.
63. Harats, D., Yacov, N., Gilburd, B., Shoenfeld, Y. & George, J. Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions. J. Am. Coll. Cardiol. 40, 1333-1338 (2002).
64. Bason, C. et al. Interaction of antibodies against cytomegalovirus with heat-shock protein 60 in pathogenesis of atherosclerosis. Lancet 362, 1971-1977 (2003).
65. Wick, G., Perschinka, H. & Mitonig, G. Atherosclerosis as an autoimmune disease: an update. Trends Immunol. 22, 665-669 (2001).
66. Mahdi, O. S., Horne, B. D., Mullen, K., Muhlestein, J. B. & Byrne, G. I. Serum immunoglobulin G antibodies to chlamydial heat shock protein 60 but not to human and bacterial homologs are associated with coronary artery disease. Circulation 106, 1659-1663 (2002).
67. Hirono, S. et al. Chlamydia pneumoniae stimulates proliferation of vascular smooth muscle cells through induction of endogenous heat shock protein 60. Circ. Res. 93, 710-716 (2003).
68. Pockley, A. G., Georgiades, A., Thulin, T., de Faire, U. & Frostegard, J. Serum heat shock protein 70 levels predict the development of atherosclerosis in subjects with established hypertension. Hypertension 42, 235-238 (2003).
69. Zhu, J. et al. Increased serum levels of heat shock protein 70 are associated with low risk of coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 23, 1055-1059 (2003).
70. Prakken, B. J. et al. Induction of IL-10 and inhibition of experimental arthritis are specific features of microbial heat shock proteins that are absent for other evolutionarily conserved immunodominant proteins. J. Immunol. 167, 4147-4153 (2001). This study shows that microbial HSPs have arthritis-protective qualities that are not seen for other non-HSP, immunogenic and conserved bacterial antigens, such as superoxide dismutase, glyceraldehyde 3-phosphate dehydrogenase and aldolase. In addition, microbial HSPs induce the production of IL-10 by T cells, whereas other bacterial antigens induce the production of pro-inflammatory cytokines.
71. Srivastava, P. Roles of heat-shock proteins in innate and adaptive immunity. Nature Rev. Immunol. 2, 185-194 (2002).
72. Binder, R. J., Vatner, R. & Srivastava, P. The heat-shock protein receptors: some answers and more questions. Tissue Antigens 64,442-451 (2004).
73. Delneste, Y. Scavenger receptors and heat-shock protein-mediated antigen cross-presentation. Biochem. Soc. Trans. 32, 633-635 (2004).
74. Millar, D. G. et al. Hsp70 promotes antigen-presenting cell function and converts T-cell tolerance to autoimmunity in vivo. Nature Med. 9, 1469-1476 (2003).
75. Bausinger, H. et al. Endotoxin-free heat-shock protein 70 fais to induce APC activation. Eur. J. Immunol. 32, 3708-3713 (2002).
76. Tsan, M. F. & Gao, B. Cytokine function of heat shock proteins. Am. J. Physiol. Cell Physiol. 286, C739-C744 (2004).
77. Vabulas, R. M. et al. Endocytosed HSP60s use Toll-like receptor 2 (TLR2) and TLR4 to activate the Toll/interleukin-1 receptor signaling pathway in innate immune cells. J. Biol. Chem. 276, 31332-31339 (2001).
78. Habich, C., Baumgart, K., Kolb, H. & Burkart, V. The receptor for heat shock protein 60 on macrophages is saturable, specific, and distinct from receptors for other heat shock proteins. J. Immunol. 168, 569-576 (2002).
79. MacAry, P. A. et al. HSP70 peptide binding mutants separate antigen delivery from dendritic cell stimulation. Immunity 20, 95-106 (2004).
80. Zanin-Zhorov, A., Nussbaum, G., Franitza, S., Cohen, I. R. & Lider, O. T cells respond to heat shock protein 60 via TLR2: actuation of adhesion and inhibition of chemokine receptors. FASEB J. 17, 1567-1569 (2003).
81. Cohen, I. R. et al. in Heat Shock Proteins and Inflammation (ed. van Eden, W.) 1-13 (Birkhauser, Basel, 2003).
82. H2 transcription factors and cytokines. J. Immunol. 174, 3227-3236 (2005).
83. Corrigall, V. M., Bodman-Smith, M. D., Brunst, M., Cornell, H. & Panayi, G. S. Inhibition of antigen-presenting cell function and stimulation of human peripheral blood mononuclear cells to express an antiinflammatory cytokine profile by the stress protein BiP: relevance to the treatment of inflammatory arthritis. Arthritis Rheum. 50,1164-1171 (2004).
84. Detanico, T. et al. Mycobacterial heat shock protein 70 induces interleukin-10 production: immunomodulation of synovial cell cytokine profile and dendritic cell maturation. Clin. Exp. Immunol. 135, 336-342 (2004).
85. Higgins, S. C. et al. Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology. J. Immunol. 171, 3119-3127 (2003).
86. Netea, M. G. et al. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J. Immunol. 172, 3712-3718 (2004).
87. Wang, X., Zou, Y., Wang, Y., Li, C. & Chang, Z. Deferential regulation of interleukin-12 and interleukin-10 by heat shock response in murine peritoneal macrophages. Biochem. Biophys. Res. Commun. 287,1041-1044 (2001).
88. Stordeur, P. & Goldman, M. Interleukin-10 as a regulatory cytokine induced by cellular stress: molecular aspects. Int. Rev. Immunol. 16, 501-522 (1998).
89. Wendung, U. et al. Aconserved mycobacterial heat shock protein (hsp) 70 sequence prevents adjuvant arthritis upon nasal administration and induces IL-10-producing T cells that cross-react with the mammalian self-hsp70 homologue. J. Immunol. 164, 2711-2717 (2000).
90. Durai, M., Kim, H. R. & Moudgil, K. D. Theregulatory C-terminal determinants within mycobacterial heat shock protein 65 are cryptic and cross-reactive with the dominant self homologs: implications for the pathogenesis of autoimmune arthritis. J. Immunol. 173, 181-188 (2004).
91. Tanaka, S. et al. Actuation of T cells recognizing an epitope of heat-shock protein 70 can protect against rat adjuvant arthritis. J. Immunol. 163, 5560-5565 (1999). In this study, an HSP70-derived peptide, which was known to be a target of regulatory T cells during infection with L. monocytogenes, was found to induce protection against experimentally induced arthritis.
92. + T cells during rat listeriosis. Int. Immunol. 10, 117-130 (1998).
93. Richman, L. K., Graeff, A. S., Yarchoan, R. & Strober, W. Simultaneous induction of antigen-specific IgA helper T cells and IgG suppressor T cells in the murine Peyer's patch after protein feeding. J. Immunol. 126, 2079-2083 (1981).
94. Chen, Y., Kuchroo, V. K., Inobe, J., Hafler, D. A. & Weiner, H. L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265, 1237-1240 (1994).
95. Samsom, J. N. Regulation of antigen-specific regulatory T-cell induction via nasal and oral mucosa. Crit. Rev. Immunol. 24, 157-177 (2004).
96. Kohashi, O. et al. Susceptibility to adjuvant-induced arthritis among germfree, specific-pathogen-free, and conventional rats. Infect. Immun. 26, 791-794 (1979).
97. Cobelens, P. M. et al. Treatment of adjuvant arthritis by oral administration of mycobacterial HSP65 during disease. Arthritis Rheum. 43, 2964-2702 (2000). In this study, ongoing adjuvant-induced arthritis was successfully treated with a low dose of oral mycobacterial HSP60, which was administered in the presence of soybean trypsin inhibitor.
98. Nieuwenhuis, E. E. et al. Oral antibiotics as a novel therapy for arthritis: evidence for a beneficial effect of intestinal Escherichia coli. Arthritis Rheum. 43, 2583-2589 (2000).
99. Bjork, J., Kleinau, S., Midtvedt, T., Klareskog, L. & Smedegard, G. Role of the bowel flora for development of immunity to hsp 65 and arthritis in three experimental models. Scand. J. Immunol. 40, 648-652 (1994).
100. Gimmi, C. D., Freeman, G. J., Gribben, J. G., Gray, G. & Nadler, L. M. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimuiation. Proc. Natl Acad. Sci. USA 90, 6586-6590 (1993).
101. Buer, J. et al. Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo. J. Exp. Med. 187, 177-183 (1998).
102. Taams, L. S. et al. Anergic T cells actively suppress T cell responses via the antigen-presenting cell. Eur. J. Immunol. 28, 2902-2912 (1998).
103. Paul, A. G., van Der Zee, R., Taams, L. S. & van Eden, W. A self-hsp60 peptide acts as a partial agonist inducing expression of B7-2 on mycobacterial hsp50-specific T cells: a possible mechanism for inhibitory T cell regulation of adjuvant arthritis? Int. Immunol. 12, 1041-1050 (2000).
104. Miyata, M., Sato, H., Sato, Y, Kodama, E. & Kasukawa, R. Significance of endogenous heat shock protein in adjuvant arthritis. J. Rheumatol. 26, 2210-2214 (1999).
105. Xiao, C. et al. Expression of the 60 kDa and 71 kDa heat shock proteins and presence of antibodies against the 71 KDa heat shock protein in pediatric patients with immune thrombocytopenic purpura. BMC Blood Disord. 4, 1 (2004).
106. Rao, D. V., Watson, K. & Jones, G. L. Age-related attenuation in the expression of the major heat shock proteins in human peripheral lymphocytes. Mech. Ageing Dev. 107, 105-118 (1999).
107. Dekker, L. et al. Safety of anti-TNFα therapy in children with juvenile idiopathic arthritis. Clin. Exp. Rheumatol. 22, 252-258 (2004).
108. Herold, K. C. et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N. Engl. J. Med. 346, 1692-1698 (2002).
109. Belghith, M. et al. TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nature Med. 9, 1202-1208 (2003).
110. Chen, Y., Kuchroo, V. K., Inobe, J., Hafler, D. A. & Weiner, H. L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265, 1237-1240 (1994).
111. Rosenthal, M., Bahous, I. & Ambrosini, G. Longterm treatment of rheumatoid arthritis with OM-8980. A retrospective study. J. Rheumatol. 18, 1790-1793 (1991).
112. Vischer, T. L. Follow-up with OM-8980 after a double-blind study of OM-8980 and auranofin in rheumatoid arthritis. Clin. Rheumatol. 9, 356-361 (1990).
113. Polla, B. S., Baladi, S., Fuller, K. & Rook, G. Presence of hsp65 in bacterial extracts (OM-89): a possible mediator of orally-induced tolerance? Experientia 51, 775-779 (1995).
114. Wendling, U. & Farine, J. C. Oral administration of HSP-containing E. coli extract OM-89 has suppressive effects in autoimmunity. Regulation of autoimmune processes by modulating peripheral immunity towards hsp's? Biotherapy 10, 223-227 (1998).
115. Bloemendal, A. et al. Experimental immunization with antirheumatic bacterial extract OM-89 induces T cell responses to heat shock protein (hsp)60 and hsp70; modulation of peripheral immunological tolerance as its possible mode of action in the treatment of rheumatoid arthritis (RA). Clin. Exp. Immunol. 110, 72-78 (1997).
116. Wulffraat, N. M. et al. Prolonged remission without treatment after autologous stem cell transplantation for refractory childhood systemic lupus erythematosus. Arthritis Rheum. 44, 728-731 (2001).
117. Prakken, B. J. et al. Artificial antigen presenting cells as a tool to exploit the immune synapse. Nature Med. 6, 1406-1410 (2000).
118. Prakken, B. J. et al. Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis. Proc. Natl Acad. Sci. USA 101, 4228-4233 (2004). This paper describes the first clinical trial of an orally administered HSP-derived peptide (dnaJ) for the treatment of arthritis. In this Phase I/II trial, the presence of peptide-specific T cells was monitored, and these cells were shown to switch from a proinflammatory cytokine-secretion profile to a regulatory cytokine-secretion profile.
119. La Cava, A. et al. Genetic bias in immune responses to a cassette shared by different microorganisms in patients with rheumatoid arthritis. J. Clin. Invest. 100, 658-663 (1997).
120. Albani, S. et al. Positive selection in autoimmunity: abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid arthritis. Nature Med. 1, 448-452 (1995).
121. H2-cytokine profile in the responding T cells.
122. Cohen, I. R. T-cell vaccination for autoimmune disease: a panorama. Vaccine 20, 706-710 (2001).
123. Sette, A. Tools of the trade in vaccine design. Science 290, 2074-2075 (2000).
124. Kamphuis, S. M. et al. Tolerogenic immune responses to novel T cell epitopes from heat shock protein 60 in juvenile idiopathic arthritis. Lancet (in the press).
125. null T cells are associated with defects in apoptotic pathways. J. Immunol. 165, 6301-6307 (2000).
126. Groh, V., Bruhl, A., El-Gabalawy, H., Nelson, J. L. & Spies, T. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc. Natl Acad. Sci. USA 100, 9452-9457 (2003).
127. null T cells in patients with acute coronary syndromes. Circulation 109, 1230-1235 (2004).
128. - cells from chagasic patients: distinct repertoire and cytokine expression. Clin. Exp. Immunol. 137, 129-138 (2004).
129. Panoutsakopoulou, V. et al. Suppression of autoimmune disease after vaccination with autoreactive T cells that express Qa-1 peptide complexes. J. Clin. Invest. 113, 1218-1224 (2004).
130. + suppressor T cells. J. Clin. Invest 114,1218-1221 (2004).
131. Davies, A. et al. A peptide from heat shock protein 60 is the dominant peptide bound to Qa-1 in the absence of the MHC class la leader sequence peptide Qdm. J. Immunol. 170, 5027-5033 (2003).
132. Hansson, G. K. Vaccination against atherosclerosis: science or fiction? Circulation 106, 1599-1601 (2002).
133. Ells, R. J. Protein folding: importance ofthe Anfinsen cage. Curr. Biol. 13, R881-R883 (2003).
134. Karlin, S. & Brocchieri, L. Heat shock protein 60 sequence comparisons: duplications, lateral transfer, and mitochondrial evolution. Proc. Natl Acad. Sci. USA 97, 11348-11353 (2000).
135. Young, J.C., Agashe, V. R., Siegers, K. & Hartl, F. U. Pathways of chaperone-mediated protein folding in the cytosol. Nature Rev. Mol. Cell Biol. 5, 781-791 (2004).
136. Karlin, S. & Brocchieri, L. Heat shock protein 70 family: multiple sequence comparisons, function, and evolution. J. Mol. Evol. 47, 565-577 (1998).
137. Boorstein, W. R., Ziegelhoffer, T & Craig, E. A. Molecular evolution of the HSP70 multigene family. J. Mol. Evol. 38, 1-17 (1994).
138. Billingham, M. E., Carney, S., Butler, R. & Colston, M. J. A mycobacterial 65-kD heat shock protein induces antigen-specific suppression of adjuvant arthritis, but is not itself arthritogenic. J. Exp. Med. 171, 339-344 (1990).
139. van den Broek, M. F. et al. Protection against streptococcal cell wall-induced arthritis by pretreatment with the 65-kD mycobacterial heat shock protein. J. Exp. Med. 170, 449-466(1989).
140. Hogervorst, E. J. et al. Modulation of experimental autoimmunity: treatment of adjuvant arthritis by immunization with a recombinant vaccinia virus. Infect. Immun. 59, 2029-2035 (1991).
141. Thompson, S. J. et al. Modulation of pristane-induced arthritis by mycobacterial antigens. Autoimmunity 11, 35-43 (1991).
142. Thompson, S. J. et al. An immunodominant epitope from mycobacterial 65-kDa heat shock protein protects against pristane-induced arthritis. J. Immunol. 160, 4628-4634 (1998).
143. Jorgensen, C., Gedon, E., Jaquet, C. & Sany, J. Gastric administration of recombinant 65 kDa heat shock protein delays the severity of type II collagen induced arthritis in mice. J. Rheumatol. 25, 763-767 (1998).
144. Ragno, S. et al. Protection of rats from adjuvant arthritis by immunization with naked DNA encoding for mycobacterial heat shock protein 65. Arthritis Rheum. 40, 277-283 (1997).
145. Moudgil, K. D. et al. Diversification of Tcell responses to carboxy-terminal determinants within the 65-kD heat-shock protein is involved in regulation of autoimmune arthritis. J. Exp. Med. 185, 1307-1316 (1997).
146. Ulmansky, R. et al. Resistance to adjuvant arthritis is due to protective antibodies against heat shock protein surface epitopes and the induction of IL-10 secretion. J. Immunol. 168, 6463-6469 (2002).
147. Prakken, B. J. et al. Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T cell epitope in rats suppresses both adjuvant arthritis and nonmicrobialty induced experimental arthritis. Proc. Natl Acad. Sci. USA 94, 3284-3289 (1997).
148. Haque, M. A. et al. Suppression of adjuvant arthritis in rats by induction of oral tolerance to mycobacterial 65-kDa heat shock protein. Eur. J. Immunol. 26, 2650-2656 (1996).
149. Ragno, S. et al. A synthetic 10-kD heat shock protein (hsp10) from Mycobacterium tuberculosis modulates adjuvant arthritis. Clin. Exp. Immunol. 103, 384-390 (1996).
150. Kingston, A. E., Hicks, C. A., Colston, M. J. & Billingham, M. E. A 71-kD heat shock protein (hsp) from Mycobacterium tuberculosis has modulatory effects on experimental rat arthritis. Clin. Exp. Immunol. 103, 77-82 (1996).
151. Ben-Nun, A., Mendel, I., Sappler, G. & Keriero de Rosbo, N. A12-kDa protein of Mycobacterium tuberculosis protects mice against experimental autoimmune encephalomyelitis. Protection in the absence of shared T cell epitopes with encephalitogenic proteins. J. Immunol. 154, 2939-2948 (1995).
152. Birnbaum, G. et al. Heat shock proteins and experimental autoimmune encephalomyelitis. II: environmental infection and extra-neuraxial inflammation alter the course of chronic relapsing encephalomyelitis. J. Neuroimmunol. 90, 149-161 (1998).
153. Rha, Y. H. et al. Effect of microbial heat shock proteins on airway inflammatbn and hyperresponsiveness. J. Immunol. 169, 5300-5307 (2002).